INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEM

1. Class action lawsuit filed against Tempus AI for potential securities fraud. 2. Spruce Point Capital reported aggressive accounting practices by Tempus. 3. Stock price of Tempus fell sharply following the release of the report. 4. Investors can join the lawsuit before August 12, 2025, as Class Plaintiffs. 5. Pomerantz LLP is leading the litigation in pursuit of class action claims.

Legal

95

5m saved

Insight

Article

FAQ

Why Very Bearish?

The announcement of the lawsuit and Spruce Point's report indicates significant concerns about TEMP's accounting practices. Historically, such legal issues often lead to a prolonged decline in stock price and investor confidence.

How important is it?

The article directly discusses a class action lawsuit against TEMP and raises red flags concerning the company's financial practices, which are critical for investor confidence.

Why Long Term?

Legal proceedings can drag on, affecting investor sentiment over time. Similar past cases have taken years to resolve, often leading to sustained downward pressure on stock prices of affected companies.

Related Companies

AZN PAI

NEW YORK, July 2, 2025 /PRNewswire/ --

Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. ("Tempus" or the "Company")(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Tempus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until August 12, 2025 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Tempus securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

Click here for information about joining the class action

On May 28, 2025, Spruce Point Capital Management ("Spruce Point") published a report on Tempus, describing a number of "concerns" about the Company. Among other issues, the Spruce Point report asserted that the Company used "aggressive accounting and financial reporting"; that several members of the Company's Board and "other executives have been associated with troubled companies that restated financial results"; and that "[k]ey strategic partnerships and deal announcement[s] with AstraZeneca and Pathos AI merit scrutiny."

On this news, Tempus's stock price fell sharply during intraday trading on May 28, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Danielle Peyton Pomerantz LLP [email protected] 646-581-9980 ext. 7980

SOURCE Pomerantz LLP